Mirror sites (1:1 microsites) for Series A companies: the 90-day install for healthcare and life sciences in the Nordics
The exact 90-day plan for standing up mirror sites (1:1 microsites) at Series A — the point where the founder can no longer be every function. Written for commercial leaders at healthtech, medtech, and life-sciences companies in the Nordics.
This edition of the Growth Broker playbook is written for commercial leaders at healthtech, medtech, and life-sciences companies operating in the Nordics. In this market, Nordic buyers reward directness, small buying committees, and a track record over a pitch, so the way you install mirror sites (1:1 microsites) has to be shaped to that reality from day one.
Series A is the moment mirror sites (1:1 microsites) stops being optional. The founder has to step out of some of the work, the plan requires a defensible growth number, and every quarter compounds toward the next raise.
Day 1 to 30: diagnosis and instrumentation. Name the constraint, write the ICP, wire meeting rate from account-specific URLs into the board pack.
Day 31 to 60: first live cycle at 20% of planned volume. Founder still in every review. Kill criteria written and enforced.
Inside healthcare and life sciences, the binding constraint is almost always regulated-sale cycle length, not intent, and in the Nordics it is compounded by the fact that reputation compounding, not campaign spend is what actually gates growth. Mirror sites (1:1 microsites) is only useful here when it is pointed at both constraints at once.
Day 61 to 90: ramp to full volume, hire the first dedicated operator, and hand off ops. Founder retains strategy and the weekly review.
By day 90 the metric is legible and the trajectory is defensible. This is what turns a Series A story into a Series B round.
Trap most Series A companies fall into: using them as brochures instead of sales rooms. It usually shows up around day 45 when the founder tries to hire ahead of the model.
The Series A version of mirror sites (1:1 microsites) looks small compared to what you will build at Series B. That is the point — it is a foundation, not a monument.
Concretely for healthcare and life sciences in the Nordics: the healthcare teams that install this get past procurement instead of dying in it, and the Nordic teams that install this compound reputation faster than any paid channel could. That is the reason it is worth installing mirror sites (1:1 microsites) deliberately for this market rather than importing a playbook designed for somewhere else.
Frequently asked questions
Microsites · healthcare · Nordics — answered
- Does mirror sites (1:1 microsites) work for healthcare and life sciences in the Nordics?
- Yes — provided it is pointed at regulated-sale cycle length, not intent and adapted to the fact that in the Nordics, Nordic buyers reward directness, small buying committees, and a track record over a pitch. The healthcare teams that install this get past procurement instead of dying in it.
- Should we start mirror sites (1:1 microsites) before Series A?
- Yes if the founder has time; the Series A version is the same model at higher spend.
- How much of the round should fund mirror sites (1:1 microsites)?
- Meaningful — often 20–30% of the growth line — but only after diagnosis.
- When do we hire the first mirror sites (1:1 microsites) operator?
- Around day 60, once the model has run one full cycle with the founder.
- What Series A trap should we avoid?
- Using them as brochures instead of sales rooms — usually a premature senior hire.
- What is the Nordics-specific pitfall when running mirror sites (1:1 microsites) for healthcare?
- Importing a playbook that was built for another market. In the Nordics, Nordic buyers reward directness, small buying committees, and a track record over a pitch — the install has to reflect that.
Growth Broker editorial
Filed under microsites · healthcare · nordics